Braveheart Bio

Braveheart Bio is focused on transforming the care of hypertrophic cardiomyopathy (HCM) through innovative treatments like BHB-1893, a cardiac myosin inhibitor aimed at improving heart performance in patients with HCM

braveheart.bio

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Braveheart Bio is focused on transforming the care of hypertrophic cardiomyopathy (HCM) through innovative treatments like BHB-1893, a cardiac myosin inhibitor aimed at improving heart performance in patients with HCM.

02Backed By1 investor

OAOrbiMed Advisors→

03Similar Companies